Tyenne — Medical Mutual

Initial criteria

• Patient has tried one other systemic therapy (e.g., corticosteroid, conventional DMARD, 1-month NSAID trial, or one biologic other than tocilizumab); AND
• Medication is prescribed by or in consultation with a rheumatologist

Reauthorization criteria

• Patient has been established on therapy for at least 6 months; AND
• Patient experienced a beneficial clinical response assessed by objective measures OR patient experienced an improvement in at least one symptom compared with baseline

Approval duration

initial: 6 months; reauth: 1 year